Bischoff R - Search Results

1

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.

van Gils MP, Stenman UH, Schalken JA, Schröder FH, Luider TM, Lilja H, Bjartell A, Hamdy FC, Pettersson KS, Bischoff R, Takalo H, Nilsson O, Mulders PF, Bangma CH. van Gils MP, et al. Among authors: bischoff r. Eur Urol. 2005 Dec;48(6):1031-41. doi: 10.1016/j.eururo.2005.06.009. Epub 2005 Jul 1. Eur Urol. 2005. PMID: 16054748 Review.

2

Differential expression of protease activity in serum samples of prostate carcinoma patients with metastases.

Dekker LJ, Burgers PC, Charif H, van Rijswijk AL, Titulaer MK, Jenster G, Bischoff R, Bangma CH, Luider TM. Dekker LJ, et al. Among authors: bischoff r. Proteomics. 2010 Jun;10(12):2348-58. doi: 10.1002/pmic.200900682. Proteomics. 2010. PMID: 20394078

3

Methodological advances in the discovery of protein and peptide disease markers.

Bischoff R, Luider TM. Bischoff R, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Apr 15;803(1):27-40. doi: 10.1016/j.jchromb.2003.09.004. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 15025996 Review.

4

Depletion of high-abundance proteins from serum by immunoaffinity chromatography: a MALDI-FT-MS study.

Dekker LJ, Bosman J, Burgers PC, van Rijswijk A, Freije R, Luider T, Bischoff R. Dekker LJ, et al. Among authors: bischoff r. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 15;847(1):65-9. doi: 10.1016/j.jchromb.2006.09.038. Epub 2006 Oct 17. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 17049934

5

Cleavable Crosslinkers as Tissue Fixation Reagents for Proteomic Analysis.

Ongay S, Langelaar-Makkinje M, Stoop MP, Liu N, Overkleeft H, Luider TM, Groothuis GMM, Bischoff R. Ongay S, et al. Among authors: bischoff r. Chembiochem. 2018 Apr 4;19(7):736-743. doi: 10.1002/cbic.201700625. Epub 2018 Feb 16. Chembiochem. 2018. PMID: 29356267

6

Molecular markers for cervical cancer screening.

Güzel C, van Sten-Van't Hoff J, de Kok IMCM, Govorukhina NI, Boychenko A, Luider TM, Bischoff R. Güzel C, et al. Among authors: bischoff r. Expert Rev Proteomics. 2021 Aug;18(8):675-691. doi: 10.1080/14789450.2021.1980387. Epub 2021 Sep 29. Expert Rev Proteomics. 2021. PMID: 34551656 Review.

7

A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer.

Boichenko AP, Govorukhina N, Klip HG, van der Zee AG, Güzel C, Luider TM, Bischoff R. Boichenko AP, et al. Among authors: bischoff r. J Proteome Res. 2014 Nov 7;13(11):4995-5007. doi: 10.1021/pr500601w. Epub 2014 Sep 29. J Proteome Res. 2014. PMID: 25232869

8

Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.

Broodman I, Lindemans J, van Sten J, Bischoff R, Luider T. Broodman I, et al. Among authors: bischoff r. J Proteome Res. 2017 Jan 6;16(1):3-13. doi: 10.1021/acs.jproteome.6b00559. Epub 2016 Nov 2. J Proteome Res. 2017. PMID: 27769114 Review.

9

Proteomic alterations in early stage cervical cancer.

Güzel C, Govorukhina NI, Wisman GBA, Stingl C, Dekker LJM, Klip HG, Hollema H, Guryev V, Horvatovich PL, van der Zee AGJ, Bischoff R, Luider TM. Güzel C, et al. Among authors: bischoff r. Oncotarget. 2018 Apr 6;9(26):18128-18147. doi: 10.18632/oncotarget.24773. eCollection 2018 Apr 6. Oncotarget. 2018. PMID: 29719595 Free PMC article.

10

Comparison of Targeted Mass Spectrometry Techniques with an Immunoassay: A Case Study for HSP90α.

Güzel C, Govorukhina NI, Stingl C, Dekker LJM, Boichenko A, van der Zee AGJ, Bischoff RPH, Luider TM. Güzel C, et al. Proteomics Clin Appl. 2018 Jan;12(1). doi: 10.1002/prca.201700107. Epub 2017 Oct 30. Proteomics Clin Appl. 2018. PMID: 28975736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

382 results

Search Page